Home > Research > Thesis
Initial preclinical safety of non-replicating human endogenous retrovirus envelope protein-coated ba
Writer : KR BIOTECH() Date : 2016-10-28 Hits : 2349  
Fime :
Initial preclinical safety of non-replicating human endogenous retrovirus envelope protein-coated baculovirus vector-based vaccines against human papillomavirus



JOURNAL OF APPLIED TOXICOLOGY



SCIE



공동



2012.07.01
Prev. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue
Next Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA